Neogen purchases genetic testing company, GVS

Food and animal safety company, Neogen Corporation, has acquired Genetic Veterinary Sciences, Inc., a genetic testing firm for companion animals.  The acquisition agreement will expand Neogen’s offerings in genomic testing. Transaction details were not shared.

"We are happy to have Genetic Veterinary Sciences (GVS) join the Neogen team," said Marylinn Munson, vice president of Genomics in Neogen. "With the growth in pet parenting globally over the past 5 years, and particularly as a result of the COVID-19 pandemic, this acquisition will further expand the opportunities for our global genomics business.”

“It is important for Neogen to continue expanding our portfolio of genomic tests and diversify our offerings in agriculture and food production to include enhanced testing for companion animals,” said Munson. “The Neogen and GVS teams will be able to combine our experiences and expertise to work synergistically, as we help meet the demands of the growing market."

Genetic Veterinary Sciences is part pf Paw Print Genetics and provides genetic data on birds, cats, and dogs for use by breeders, pet owners, and veterinarians.

"Joining Neogen is a wonderful opportunity for Paw Print Genetics and our related brands," said Lisa Shaffer, founder and chief executive officer of GVS. " The focus on quality and accuracy, which has been a hallmark of GVS, coupled with the global reach and expertise from Neogen, will continue to grow the companion animal market and deliver solutions focused on the health and wellbeing of pets and the human-animal bond."

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.


Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)


Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update


Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer


Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).




News of interest


Copyright © 2024 - All Rights Reserved
ISSN 2768-198X